402 related articles for article (PubMed ID: 31233276)
1. Glutaminase 1 Inhibition Reduces Glycolysis and Ameliorates Lupus-like Disease in MRL/lpr Mice and Experimental Autoimmune Encephalomyelitis.
Kono M; Yoshida N; Maeda K; Suárez-Fueyo A; Kyttaris VC; Tsokos GC
Arthritis Rheumatol; 2019 Nov; 71(11):1869-1878. PubMed ID: 31233276
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of glutaminolysis ameliorates lupus by regulating T and B cell subsets and downregulating the mTOR/P70S6K/4EBP1 and NLRP3/caspase-1/IL-1β pathways in MRL/lpr mice.
Zhang X; Wang G; Bi Y; Jiang Z; Wang X
Int Immunopharmacol; 2022 Nov; 112():109133. PubMed ID: 36113317
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional factor ICER promotes glutaminolysis and the generation of Th17 cells.
Kono M; Yoshida N; Maeda K; Tsokos GC
Proc Natl Acad Sci U S A; 2018 Mar; 115(10):2478-2483. PubMed ID: 29463741
[TBL] [Abstract][Full Text] [Related]
4. Promotion of Calcium/Calmodulin-Dependent Protein Kinase 4 by GLUT1-Dependent Glycolysis in Systemic Lupus Erythematosus.
Koga T; Sato T; Furukawa K; Morimoto S; Endo Y; Umeda M; Sumiyoshi R; Fukui S; Kawashiri SY; Iwamoto N; Ichinose K; Tamai M; Origuchi T; Nakamura H; Kawakami A
Arthritis Rheumatol; 2019 May; 71(5):766-772. PubMed ID: 30462889
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of microRNA-448 suppresses CD4
Zhang J; Guo Y; Sun Y; Chang L; Wang X
Biochem Biophys Res Commun; 2022 Mar; 596():88-96. PubMed ID: 35121374
[TBL] [Abstract][Full Text] [Related]
6. IL-6/STAT3 pathway induced deficiency of RFX1 contributes to Th17-dependent autoimmune diseases via epigenetic regulation.
Zhao M; Tan Y; Peng Q; Huang C; Guo Y; Liang G; Zhu B; Huang Y; Liu A; Wang Z; Li M; Gao X; Wu R; Wu H; Long H; Lu Q
Nat Commun; 2018 Feb; 9(1):583. PubMed ID: 29422534
[TBL] [Abstract][Full Text] [Related]
7. The role of GLS1-mediated glutaminolysis/2-HG/H3K4me3 and GSH/ROS signals in Th17 responses counteracted by PPARγ agonists.
Miao Y; Zheng Y; Geng Y; Yang L; Cao N; Dai Y; Wei Z
Theranostics; 2021; 11(9):4531-4548. PubMed ID: 33754076
[No Abstract] [Full Text] [Related]
8. Pyruvate dehydrogenase phosphatase catalytic subunit 2 limits Th17 differentiation.
Kono M; Yoshida N; Maeda K; Skinner NE; Pan W; Kyttaris VC; Tsokos MG; Tsokos GC
Proc Natl Acad Sci U S A; 2018 Sep; 115(37):9288-9293. PubMed ID: 30150402
[TBL] [Abstract][Full Text] [Related]
9. Cutting Edge: Nanogel-Based Delivery of an Inhibitor of CaMK4 to CD4+ T Cells Suppresses Experimental Autoimmune Encephalomyelitis and Lupus-like Disease in Mice.
Otomo K; Koga T; Mizui M; Yoshida N; Kriegel C; Bickerton S; Fahmy TM; Tsokos GC
J Immunol; 2015 Dec; 195(12):5533-7. PubMed ID: 26561550
[TBL] [Abstract][Full Text] [Related]
10. Molecular targeting of glutaminase sensitizes ovarian cancer cells to chemotherapy.
Masamha CP; LaFontaine P
J Cell Biochem; 2018 Jul; 119(7):6136-6145. PubMed ID: 29633308
[TBL] [Abstract][Full Text] [Related]
11. Resolvin D1 Improves the Treg/Th17 Imbalance in Systemic Lupus Erythematosus Through miR-30e-5p.
Cheng T; Ding S; Liu S; Li X; Tang X; Sun L
Front Immunol; 2021; 12():668760. PubMed ID: 34093566
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological Inhibition of Glutaminase 1 Normalized the Metabolic State and CD4+ T Cell Response in Sjogren's Syndrome.
Fu J; Pu Y; Wang B; Li H; Yang X; Xie L; Shi H; Wang Z; Yin J; Zhan T; Shao Y; Chen C; Luo Q; Xu J; Zong Z; Wei X; Xiao W; Yu C; Zheng L
J Immunol Res; 2022; 2022():3210200. PubMed ID: 35211629
[TBL] [Abstract][Full Text] [Related]
13. Upregulated IL-1 Receptor-associated Kinase 1 (IRAK1) in Systemic Lupus Erythematosus: IRAK1 Inhibition Represses Th17 Differentiation with Therapeutic Potential.
Zhou Z; Tian Z; Zhang M; Zhang Y; Ni B; Hao F
Immunol Invest; 2018 Jul; 47(5):468-483. PubMed ID: 29611775
[TBL] [Abstract][Full Text] [Related]
14. Glutaminase 1 regulates the release of extracellular vesicles during neuroinflammation through key metabolic intermediate alpha-ketoglutarate.
Wu B; Liu J; Zhao R; Li Y; Peer J; Braun AL; Zhao L; Wang Y; Tong Z; Huang Y; Zheng JC
J Neuroinflammation; 2018 Mar; 15(1):79. PubMed ID: 29540215
[TBL] [Abstract][Full Text] [Related]
15. Targeting cellular metabolism to reduce head and neck cancer growth.
Yang J; Guo Y; Seo W; Zhang R; Lu C; Wang Y; Luo L; Paul B; Yan W; Saxena D; Li X
Sci Rep; 2019 Mar; 9(1):4995. PubMed ID: 30899051
[TBL] [Abstract][Full Text] [Related]
16. Effect of lysine to alanine mutations on the phosphate activation and BPTES inhibition of glutaminase.
McDonald CJ; Acheff E; Kennedy R; Taylor L; Curthoys NP
Neurochem Int; 2015 Sep; 88():10-4. PubMed ID: 25510640
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and pharmacological evaluation of bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide 3 (BPTES) analogs as glutaminase inhibitors.
Shukla K; Ferraris DV; Thomas AG; Stathis M; Duvall B; Delahanty G; Alt J; Rais R; Rojas C; Gao P; Xiang Y; Dang CV; Slusher BS; Tsukamoto T
J Med Chem; 2012 Dec; 55(23):10551-63. PubMed ID: 23151085
[TBL] [Abstract][Full Text] [Related]
18. Combination therapy with BPTES nanoparticles and metformin targets the metabolic heterogeneity of pancreatic cancer.
Elgogary A; Xu Q; Poore B; Alt J; Zimmermann SC; Zhao L; Fu J; Chen B; Xia S; Liu Y; Neisser M; Nguyen C; Lee R; Park JK; Reyes J; Hartung T; Rojas C; Rais R; Tsukamoto T; Semenza GL; Hanes J; Slusher BS; Le A
Proc Natl Acad Sci U S A; 2016 Sep; 113(36):E5328-36. PubMed ID: 27559084
[TBL] [Abstract][Full Text] [Related]
19. Spontaneous colitis in IL-10-deficient mice was ameliorated via inhibiting glutaminase1.
Li J; Zuo L; Tian Y; He Y; Zhang Z; Guo P; Ge Y; Hu J
J Cell Mol Med; 2019 Aug; 23(8):5632-5641. PubMed ID: 31211512
[TBL] [Abstract][Full Text] [Related]
20. Chloroquine Autophagic Inhibition Rebalances Th17/Treg-Mediated Immunity and Ameliorates Systemic Lupus Erythematosus.
An N; Chen Y; Wang C; Yang C; Wu ZH; Xue J; Ye L; Wang S; Liu HF; Pan Q
Cell Physiol Biochem; 2017; 44(1):412-422. PubMed ID: 29141242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
